REFERENCES
- Schmitz O. Glucose metabolism in non-diabetic and insulin dependent diabetic subjects with end stage renal failure. Dan Med Bull 1991; 38(1)32–56
- Mak R H, Wong J H. The Vitamin D/Parathyroid hormone axis in the pathogenesis of hypertension and insulin resistance in uremia. Miner Electrolyte Metab 1992; 18: 156–159
- Mak R H. Correction of anemia by erythropoietin reverses insulin resistance and hyperinsulinemia in uremia. Am J Phsiol 1996; 270: 839–844
- Foss M C, Gouveia L M, Neto M M, Paccola G M, Piccinato C E. Effect of hemodialysis on peripheral glucose metabolism of patients with chronic renal failure. Nephron 1996; 73: 48–53
- Mak R H. Insulin resistance in uremia effect of dialysis modality. Pediatar Res 1996; 40(2)304–308
- Gunal A I, Celiker H, Celebi H, Ustundag B, Gunal S Y. Intravenous alfacalcidol improves insulin resistance in hemodialysis patients. Clin Nephrol 1997; 48(2)109–113
- Harano Y, Suzuki M, Shinozaki K, Hara Y, Ryomoto K, Kayoko R, Kanazawa A, Nishioheda Y, Tsushima M. Clinical impact of insulin resistance syndrome in cardiovascular disease and its therapeutic approach. Hypertens Res 1996; 19(Suppl. I)S81–85
- Suzuki M, Ikebuchi M, Shinozaki K, Hara Y, Tsushima M, Matsuyama T, Harano Y. Mechanism and clinical implication of insulin resistance. Diabetes 1996; 45(suppl. 3)S52–S54
- Mykkanen L, Haffner S M, Ronnemaa T, Bergman R N, Laakso M. Low insulin sensitivity is associated with clustering of cardiovascular disease risk factor. Am J Epidemiology 1997; 146: 315–321
- Ma K W, Greene E L, Raij L. Cardiovascular risk factors in chronic renal failure and hemodialysis populations. Am J Kidney Dis 1992; 19(6)505–513
- Harano Y, Kageyama A, Hirose J, Asakura Y, Yokota T, Ikebuchi M, Suzuki M, Omae T. Improvement of insulin sensitivity for glucose metabolism with long acting Ca-channel blocker amlodipine in essential hypertensive subjects. Metabolism 1995; 44(3)315–319
- Suzuki M, Ikebuchi M, Yokota C, Shinozaki K, Harano Y. Normalization of insulin resistance in none obese essential hypertension by Cilazapril treatment. Clin Exp Hypertens 1995; 17: 1257–1268
- Kageyama S, Yamamoto J, Mimura A, Sakurai T, Ishibashi K, Aihara K, Taniguchi I, Ito K, Isogai Y. Doxazosin improves insulin sensitivity in hypertensive patients. Clin Ther 1993; 15(5)829–837
- Andersson P E, Johansson J, Berne C, Lithell H. Effect of selective alfa 1 and beta 1 adrenoreceptor blockade on lipoprotein and carbohydrate metabolism in hypertensive subjects, with special emphasis on insulin sensitivity. J Hum Hypertens 1994; 8(3)219–226
- Moan A, Hoieggen A, Nordby G, Eida I K, Kjeldsen S E. Effect of losartan on insulin sensitivity in severe hypertension connection through sympathetic nervous system activity?. J Hum Hypertens 1995; 5: s45–s50
- Higashiura K, Ura N, Miyazaki Y, Shimamoto K. Effect of an angiotensin II receptor antagonist, candesartan, on insulin resistance and pressor mechanisms in essential hypertension. J Hum Hypertens 1999; 12(Suppl 1)71–74
- Paolisso G, Tagliamonte M R, Gambardella A, Manzella D, Gualdiero P, Varricchio G, Verza M, Varricchio M. Losartan mediated improvement in insulin action is mainly due to an increase in non-oxidative glucose metabolism and blood flow in insulin-resistant hypertensive patients. J Hypertens 1997; 11: 307–312
- Matthews D R, Hosker J P, Rudenski A S, Naylor B A, Treacher D F, Turner R C. Homeostasis model assessment Insulin resistance and b cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412–419
- Laakso M, Karjalainen L, Lempiainen-Kuosa P. Effect of Losartan on insulin sensitivity in hypertensive subjects. Hypertension 1996; 28: 392–396
- Fogari R, Zoppi A, Corradi L, Lazzari P, Mugellini A, Lusardi P. Comparative effects of lisinopril and losartan on insulin sensitivity in the treatment of non diabetic hypertensive patients. Br J Clin Pharmacol 1998; 46(5)467–471